Dedicated to Research Since 1993

Medical Marijuana Market By Product Type (Sativa, Indica, Hybrid) By Chemical Component (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Hybrid (Combination of THC & CBD)) By Application(Cancer, Arthritis, Material Handling, Alzheimer’s, Pain Management ) By End-User (Hospitality, Pharmaceutical Industry, Research and Development Centers)- Global Size Analysis and Industry Forecast, 2018-2023.

 Healthcare and Pharmaceuticals

Report Overview

GLOBAL MEDICAL MARIJUANA MARKET was valued at USD 9.01 Billion in the year 2017. Global Medical marijuana market is further estimated to grow at a CAGR of 16.90% from 2018 to reach USD 23.3 Billion by the year 2023.

North America region holds the highest market share in 2017 and Europe market is considered as the fastest growing market in the forecasted period due to growing demand in the healthcare industry and technological advancements. At a country level, U.S & Canada is projected to grow strongly in the coming years.

Canopy Growth Corporation (Canada), Medical Marijuana, Inc. (U.S), GW Pharmaceuticals, plc (U.K), United Cannabis (U.S), Cannabis Sativa, Inc. (U.S), GreenGro Technologies (U.S), Aurora Cannabis (Canada), Cara Therapeutics (U.S) and GBSciences, Inc. (U.S) are the key players in the Global Medical marijuana  market. Better global reach at an operational level is the main reason the key players are holding substantial market share. Rising research and development expenses to satisfy the changing demands of end users, new product launches and organic growth strategies were few techniques adopted by various manufacturers in last 5 years.


            The expansion of marijuana legalization in the U.S.


            The stigma of marijuana in society

            Lack of federal support


            Cannabis as healthcare treatment


            Legal Issues

The segmentation are done on the basis of Type of marijuana, by chemical component, by application, by end-use and by region. On the basis of Product Type, the Sativa segment is expected to hold the highest market share during the forecast period due to growing awareness and high demand. The segmentation done on the basis of Chemical Component the Tetrahydrocannabinol (THC) segment is expected to hold the highest market share.

Medical Marijuana Industry on the basis of application in this report include Cancer, Arthritis, and Alzheimer’s, Pain Management, Multiple Sclerosis and Others. Pain Management segment hold the largest share and it is also the fastest growing with the CAGR of XX% in the forecasted period.

The segmentation done on the basis of end use includes hospital, pharmaceutical industry and research and development centers of which the pharmaceutical industry segment is expected to hold the highest market share during the forecast period.

Key Benefits for Stakeholders

Medical marijuana Manufacturers, Distributors and Retailers

Raw material suppliers

Research and Consulting Organization

Medical and, R&D and healthcare institutions

By Product Type




By Chemical Component

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Hybrid (Combination of THC & CBD)

By Application




Pain Management

Multiple Sclerosis


By End-User


Pharmaceutical Industry

Research and Development Centers

By Region

North America




Key Market Players

Canopy Growth Corporation

GW Pharmaceuticals, PLC

Medical Marijuana, Inc.

United Cannabis Corporation

Cannabis Sativa, Inc.

GreenGro Technologies

Aurora Cannabis

United Cannabis Corporation

Cara Therapeutics.

GBSciences, Inc.

(A brief overview of 10 companies is also provided)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1. Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2. Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3. To avoid bias, we filter the collected data collected from authenticated sources.
  4. GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5. Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6. Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet with your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

    Key Data from Secondary Research

       2.1.2. Primary Research

    Key Data from Primary Research

    Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary


4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Medical Marijuana Market, By Product Type

6.1. Sativa

6.2. Indica

6.3. Hybrid

7. Medical Marijuana Market, By Chemical Component

7.1. Tetrahydrocannabinol (THC)

7.2. Cannabidiol (CBD)

7.3. Hybrid (Combination of THC & CBD)

8. Medical Marijuana Market, By Application

8.1. Cancer

8.2. Arthritis

8.3. Alzheimer’s

8.4. Pain Management

8.5. Multiple Sclerosis

8.6. Others

9. Medical Marijuana Market, End-Use

9.1. Hospitality

9.2. Pharmaceutical Industry

9.3. Research and Development Centers

10. Geographical Analysis

10.1. Introduction

10.2. North America

            10.2.1. U.S.

            10.2.2. Canada

            10.2.3. Mexico

10.3. Europe

            10.3.1. U.K.

            10.3.2. Germany

            10.3.3. Italy

            10.3.4. France

            10.3.5. RoE

10.4. Asia Pacific

            10.4.1. South Korea

            10.4.2. China

            10.4.3. Japan

            10.4.4. India

            10.4.5. RoAPAC

10.5. RoW

            10.5.1. Latin America

            10.5.2. Middle East and Africa

11. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

11.1. Canopy Growth Corporation

11.2. GW Pharmaceuticals, PLC

11.3. Medical Marijuana, Inc.

11.4. United Cannabis Corporation

11.5. Cannabis Sativa, Inc.

11.6. GreenGro Technologies

11.7. Aurora Cannabis

11.8. United Cannabis Corporation

11.9. Cara Therapeutics.

11.10. GBSciences, Inc.

 (Another brief information of 10 companies will be provided in report.)

12. Competitive Analysis

12.1. Introduction

12.2. Market Positioning of Key Players

12.3 Competitive Strategies Adopted by Leading Players

            12.3.1. Investments & Expansions

            12.3.2. New Product Launches

            12.3.3. Mergers & Acquisitions

            12.3.4. Agreements, Joint Ventures, and Partnerships

13. Appendix

13.1. Questionnaire

13.2. Available Customizations

13.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)


No Content Available.